Pressmeddelande -

Founders Increase Their Shareholding

Before the IPO of Swedish medtech company Brighter AB (publ) was launched, the founders, Michael Frantzén and Truls Sjöstedt, increased their shareholding by a total of 875 000 shares in Brighter, corresponding to 8.74% of the total capital stock (437 500 shares and 4.37% respectively).

”The acquisition is to be seen as a sign of our long-term belief in the company that we have founded, and in the future, before which Brighter stands with an upcoming commercialization of Brighter One, the market’s first complete all-in-one-instrument for self-care of diabetes that Brighter has patented.” says Truls Sjöstedt, CEO of Brighter AB (publ).

About Brighter AB (publ)

Brighter develops and commercializes innovative solutions for diabetes self-cafe. It is a STING Alumni company. Financing has come from state and institutional investors such as ALMIInnovationsbron, KAS Innovationsfond (an activity within the Karl-Adam Bonnier foundation) as well as from private investors.

During the period August 15 to September 26, there is a unique opportunity to issue shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget. For more information: www.BrighterCompany.com.

Brighter's all-in-one solution: Brighter One TM Full Video

Contact Information

http://www.BrighterCompany.com/

http://www.BrighterCompany.com/video

http://www.facebook.com/brightercompany

http://twitter.com/Brighter_AB


Phone: +46 8 55 00 88 20

Fax: +46 8 55 00 88 30


Truls Sjöstedt, VD på Brighter AB (publ)

Phone: +46 709 73 46 00

E-mail: truls.sjostedt@brightercompany.com

 

Ämnen

  • Medicinsk forskning

Kategorier

  • diabetes
  • medtech
  • listning
  • shareholding
  • acquisition
  • future

Brighter develops and commercializes innovative solutions for diabetes self-cafe. It is a STING Alumni company. Financing has come from state and institutional investors such as ALMIInnovationsbron, KAS Innovationsfond (an activity within the Karl-Adam Bonnier foundation) as well as from private investors.

During the period August 15 to September 2, there is a unique opportunity to issue shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget. For more information: www.BrighterCompany.com.

Brighter's all-in-one solution: Brighter One TM Full Video

Kontakter

  • Brighter One TM
    Licens:
    All rights reserved
  • Investeringsmemorandum
    Investeringsmemorandum
    Licens:
    All rights reserved
    Filformat:
    .pdf
  • Inbjudan till att teckna aktier
    Inbjudan till att teckna aktier
    Licens:
    All rights reserved
    Filformat:
    .pdf
  • Teckningssedel
    Teckningssedel
    Licens:
    All rights reserved
    Filformat:
    .pdf

Relaterat innehåll

  • Brighter Sheds Light on the Darkness of the Stock Markets

    In the middle of one of the darkest periods on the stock markets, medtech company Brighter AB (publ) invites to its IPO at AktieTorget with the purpose to attract 8.5 MSEK. With the main patent approved a year earlier than planned, Brighter leaves the development period and goes on to commercializing the product portfolio Brighter One TM, an attractive world news with great global potential.

  • Brighter Has Launched Its Initial Public Offering Period

    Brighter AB (publ) has launched its Initial Public Offering period at AktieTorget as promised. The company has developed and patented the world’s first all-in-one self-care device for diabetics that does not need to be attached to the body. Now, the public is offered a unique opportunity to take part in Brighter’s future growth through the IPO.